ICMR issues revised advisory to state governments regarding Rapid Antibody Blood tests

ICMR has written to them to stop using Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics kits.

Updated: Apr 27, 2020 16:22 IST


Hari Aditya

Tags: India Corona

ICMR's Revised Advisory

ICMR supports RT-PCR throat nasal swab check as the safest option for Covid 19 diagnosis. The RT-PCR test identifies the virus early and is the best technique for detecting the person and isolating them. Several states have procured rapid antibody test kits and ICMR has also issued such kits with specific guidance on their demand that they should be used for surveillance purposes only. Throughout the testing exercise they underwent, some states classified issues about their results. ICMR-ICMR. Afterward. The Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics Kits have both been tested under field conditions. Given early hope of strong success for surveillance purposes, the findings revealed large variability in their sensitiveness. In the context of that. States are urged to avoid using the kits procured from the companies listed above and return them to the suppliers.